(LYEL) Lyell Immunopharma - Performance -73.6% in 12m
LYEL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-84.65%
#152 in Peer-Group
Rel. Strength
4.13%
#7368 in Stock-Universe
Total Return 12m
-73.55%
#166 in Peer-Group
Total Return 5y
-97.31%
#161 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 37.60 USD |
| 52 Week Low | 7.80 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 48.46 |
| Buy/Sell Signal +-5 | -1.91 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: LYEL (-73.6%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-2.07% | 25.1% | -6.95% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.57% | 27.9% | 14.5% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: LYEL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for LYEL
| Total Return (including Dividends) | LYEL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -10.52% | 3.06% | 3.54% |
| 3 Months | -0.87% | 12.25% | 16.07% |
| 12 Months | -73.55% | -13.98% | 12.18% |
| 5 Years | -97.31% | -27.36% | 107.69% |
| Trend Score (consistency of price movement) | LYEL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.5% | 76.5% | 91.9% |
| 3 Months | 42.4% | 79.3% | 97.5% |
| 12 Months | -92.9% | -87.3% | 47% |
| 5 Years | -95.1% | -51.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th15.00 | -13.17% | -13.58% |
| 3 Month | %th30.00 | -11.69% | -14.59% |
| 12 Month | %th18.00 | -69.25% | -76.42% |
| 5 Years | %th22.50 | -95.79% | -98.28% |
FAQs
Does Lyell Immunopharma (LYEL) outperform the market?
No,
over the last 12 months LYEL made -73.55%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.98%.
Over the last 3 months LYEL made -0.87%, while XBI made 12.25%.
Performance Comparison LYEL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
LYEL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.8% | -14.1% | -29.4% | -86% |
| US NASDAQ 100 | QQQ | -3.3% | -14.8% | -31.8% | -86% |
| German DAX 40 | DAX | -1.9% | -12.1% | -40.1% | -102% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.4% | -15.5% | -33.4% | -93% |
| Hongkong Hang Seng | HSI | -3.4% | -13% | -51.4% | -108% |
| India NIFTY 50 | INDA | -1.1% | -11.1% | -30.8% | -70% |
| Brasil Bovespa | EWZ | 1.8% | -7.6% | -41.5% | -74% |
LYEL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.8% | -12.4% | -33.5% | -97% |
| Consumer Discretionary | XLY | -3.2% | -13.1% | -20.7% | -89% |
| Consumer Staples | XLP | -1% | -9.8% | -30.1% | -80% |
| Energy | XLE | -0.7% | -10.2% | -19.2% | -71% |
| Financial | XLF | -1.5% | -13.1% | -28.9% | -95% |
| Health Care | XLV | -0.8% | -8.7% | -18.9% | -65% |
| Industrial | XLI | -3.2% | -15.2% | -35.3% | -95% |
| Materials | XLB | -0.2% | -12.2% | -27.2% | -74% |
| Real Estate | XLRE | -2.3% | -9.9% | -28.2% | -80% |
| Technology | XLK | -3.2% | -16.8% | -35.2% | -84% |
| Utilities | XLU | -3.6% | -12.4% | -32.1% | -95% |
| Aerospace & Defense | XAR | -5.7% | -19.7% | -49.9% | -122% |
| Biotech | XBI | -3.9% | -13.6% | -20.8% | -60% |
| Homebuilder | XHB | -1.1% | -16% | -16% | -67% |
| Retail | XRT | -1.6% | -13.4% | -25.2% | -78% |
LYEL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.3% | -6.28% | -13.0% | -67% |
| Natural Gas | UNG | -7.3% | -2% | -5.1% | -81% |
| Gold | GLD | -3.4% | -8.9% | -47% | -111% |
| Silver | SLV | -5.4% | -14.2% | -46.3% | -96% |
| Copper | CPER | -4.1% | -24.1% | -48.1% | -96% |
LYEL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.3% | -10.4% | -23.9% | -69% |
| iShares High Yield Corp. Bond | HYG | -2.3% | -11.4% | -27.4% | -82% |